Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment

Open Forum Infectious Diseases

Volumn 1, Issue 2, 2014, Pages

  El sayed, Dena ^a   Grotts, Jonathan ^a,b   Golgert, William A ^a,c   Sugar, Alan M ^a,c  

^a SANTA BARBARA COTTAGE HOSPITAL   (United States)

^b Department of Research ^*  (United States)

^c Sansum Clinic   (United States)

Author keywords

Bacterial infections; Procalcitonin; Renal insufficiency; Sensitivity; Specificity

Indexed keywords

PROCALCITONIN;

ADULT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 84964213035     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu068     Document Type: Article

References (22)

1. Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010; 8:575-87.
2. Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004; 8:R234-42.
3. Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and Creactive protein as markers of sepsis. Crit Care Med 2003; 31:1737-41.
4. Lee S, Chan R, Wu J, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients-a systematic review and meta-analysis. Int J Clin Pract 2013; 67:1350-7.
5. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011; 39:2048-58.
6. Kylanpaa-Back ML, Takala A, Kemppainen EA, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001; 29:63-9.
7. Stam F, van Guldener C, Schalkwijk CG, et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003; 18:892-8.
8. Steinbach G, Bolke E, Grunert A, et al. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 2004; 116:849-853.
9. Level C, Chauveau P, Delmas Y, et al. Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001; 16:980-6.
10. Sitter T, Schmidt M, Schneider S, et al. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 2002; 15:297-301.
11. Koeze J, Hendrix MG, van den Bergh FA, et al. In critically ill patients the procalcitonin level can be misleading. Crit Care 2011; 15:422.
12. Schutzle H, Forster J, Superti-Furga A, et al. Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis. Eur J Pediatr 2009; 168:1117-24.
13. Prat C, Dominguez J, Rodrigo C, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 2003; 22:963-8.
14. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community- acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009; 168:1429-36.
15. Herget-Rosenthal S, Klein T, Marggraf G, et al. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 2005; 61:180-6.
16. Lu X, Xiao Z, Yang M, Zhu Y. Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol Dial Transplant 2013; 28:122-9.
17. Schmidt M, Burchardi C, Sitter T, et al. Procalcitonin in patients undergoing chronic hemodialysis. Nephron 2000; 84:187-8.
18. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
19. Herget-Rosenthal S, Marggraf G, Pietruck F, et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001; 16:975-9.
20. Goolsby MJ. National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. J Am Acad Nurse Pract 2002; 14:238-42.
21. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999; 18:875-81.
22. Meisner M, Schmidt J, Huttner H, et al. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000; 26(Suppl 2):S212-6.